124 related articles for article (PubMed ID: 10744202)
21. Medical control of intraocular pressure after phacoemulsification.
Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
[TBL] [Abstract][Full Text] [Related]
22. Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
Fogagnolo P; Centofanti M; Figus M; Frezzotti P; Fea A; Ligorio P; Lembo A; Digiuni M; Lorenzi U; Rossetti L
Ophthalmologica; 2012; 228(3):154-8. PubMed ID: 22572718
[TBL] [Abstract][Full Text] [Related]
23. Treatment of intraocular pressure elevation after photorefractive keratectomy.
Nagy ZZ; Szabó A; Krueger RR; Süveges I
J Cataract Refract Surg; 2001 Jul; 27(7):1018-24. PubMed ID: 11489570
[TBL] [Abstract][Full Text] [Related]
24. Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination: randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens.
Wirtitsch MG; Menapace R; Georgopoulos M; Rainer G; Buehl W; Heinzl H
J Cataract Refract Surg; 2007 Oct; 33(10):1754-9. PubMed ID: 17889772
[TBL] [Abstract][Full Text] [Related]
25. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
26. Oral versus topical carbonic anhydrase inhibitors in ocular hypertension after scleral tunnel cataract surgery.
Al-Barrag A; Al-Shaer M; Al-Matary N; Bamashmous M
Clin Ophthalmol; 2009; 3():357-62. PubMed ID: 19668590
[TBL] [Abstract][Full Text] [Related]
27. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor.
Lippa EA; Carlson LE; Ehinger B; Eriksson LO; Finnström K; Holmin C; Nilsson SE; Nyman K; Raitta C; Ringvold A
Arch Ophthalmol; 1992 Apr; 110(4):495-9. PubMed ID: 1562255
[TBL] [Abstract][Full Text] [Related]
28. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
Strahlman E; Tipping R; Vogel R
Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
Strohmaier K; Snyder E; DuBiner H; Adamsons I
Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
[TBL] [Abstract][Full Text] [Related]
32. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
Strohmaier K; Snyder E; DuBiner H; Adamsons I
Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
Detry-Morel M; De Hoste F
Bull Soc Belge Ophtalmol; 1997; 267():157-66. PubMed ID: 9745826
[TBL] [Abstract][Full Text] [Related]
35. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
36. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
Balfour JA; Wilde MI
Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
[TBL] [Abstract][Full Text] [Related]
37. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study.
Centofanti M; Manni GL; Napoli D; Bucci MG
Pharmacol Res; 1997 May; 35(5):481-5. PubMed ID: 9299215
[TBL] [Abstract][Full Text] [Related]
39. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
Kir E; Cakmak H; Dayanir V
Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
[TBL] [Abstract][Full Text] [Related]
40. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
Manni GL; Centofanti M; Napoli D; Parisi V; Bucci MG
Acta Ophthalmol Scand Suppl; 1997; (224):22-3. PubMed ID: 9589714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
